Recent Advances in Assisted Reproductive Technology

被引：0
作者：
Paul R. Brezina
Ning Ning
Eric Mitchell
Howard A. Zacur
Theodore A. Baramki
Yulian Zhao
机构：
[1] Johns Hopkins Medical Institutions,Department of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility
[2] Harbin Medical University,Department of Obstetrics and Gynecology, The First Affiliated Hospital
[3] University of Tennessee College of Medicine-Chattanooga,Department of Obstetrics and Gynecology
来源：
Current Obstetrics and Gynecology Reports | 2012年 / 1卷 / 4期
关键词：
In vitro Fertilization; IVF; Preimplantation genetic screening; PGS; Preimplantation genetic diagnosis; PGD; Preimplantation genetic testing; Metabolomics; Proteomics; In vitro maturation; Review; Embryo biopsy; Fluorescence in situ hybridization; FISH; Embryo cryopreservation; Oocyte cryopreservation; Egg bank; Oocyte bank; Fertility preservation; Oncology; Time lapse; Videography; Fertility; Infertility; Infertile;
D O I：
10.1007/s13669-012-0019-2
中图分类号：
学科分类号：
摘要：
In 1978 the world witnessed the birth of the first “test tube baby.” Since this time there have been explosive advances in assisted reproductive technologies (ART). Current optimizations surrounding the delivery of in vitro fertilization (IVF) including the utilization of minimal stimulation protocols and gonadotropin releasing hormone (GnRH) agonist cycle triggers are being increasingly utilized to maximize patient safety. Modifications, such as those seen in the embryology laboratory, continue to improve pregnancy rates. Concurrent with these advancements in IVF have been the emergence of related technologies, such as embryonic genetic testing and oocyte preservation, which potentially have broad applications to both fertile and infertile couples. As these relevant applications of ART become increasingly utilized, it is incumbent upon society to ensure that these resources are made available in a morally responsible and equitable manner.
引用
收藏
页码：166 / 173
页数：7
相关论文
共 213 条
[1]  
Steptoe PC(1978)Birth after the reimplantation of a human embryo Lancet 2 366-3
[2]  
Edwards RG(2008)The use of controlled ovarian hyperstimulation (COH) in clinical in vitro fertilization: the role of Georgeanna Seegar Jones Fertil Steril 90 e1-8
[3]  
Jones HW(2012)The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial Reprod Biol Endocrinol 10 16-109
[4]  
Brezina PR(1992)Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte Lancet 340 17-20
[5]  
Vlahos NF(2011)Laser assisted zona hatching: what is the evidence to justify its use? Middle East Fertil Soc J 16 107-34
[6]  
Lai T(2010)The art and science of embryo transfer: what information are we lacking? Middle East Fertil Soc J 15 14-9
[7]  
Palermo G(1984)Three years of in vitro fertilization at Norfolk Fertil Steril 42 826-15
[8]  
Joris H(1985)The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization Fertil Steril 44 62-25
[9]  
Devroey P(2003)A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment Fertil Steril 79 308-9
[10]  
Van Steirteghem AC(2009)Ovulation triggering with GnRH agonist vs. hCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized cross-over trial J Assist Reprod Genet 26 251-8
12345678910